Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
TD Cowen Reiterates Buy Rating on Sutro Biopharma (STRO)
-
TD Cowen Reiterates Buy Rating on Sutro Biopharma (STRO)
-
Sutro Biopharma to Participate in Upcoming Investor Conferences
-
Sutro Biopharma and Blackstone Announce Royalty Financing Collaboration
-
Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference
-
Sutro Biopharma to Participate in the Cowen 42nd Annual Healthcare Conference
-
Sutro Biopharma to Participate in Upcoming Virtual Investor Conferences
-
Sutro Biopharma to Participate in the Cowen 41st Annual Healthcare Conference
-
Sutro Biopharma Announces Closing of Upsized $144.9 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Sutro Biopharma Inc. (STRO) Prices 6M Share Common Offering at $21/Sh
-
Sutro Biopharma Announces Pricing of $126.0 Million Public Offering
-
Sutro Biopharma (STRO) Announces Proposed Public Offering of 5 Million Shares of Common Stock
-
Sutro Biopharma Announces Proposed Public Offering of 5 Million Shares of Common Stock
-
Sutro Biopharma Announces Closing of $98.0 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
-
Sutro Biopharma Inc. (STRO) Prices 11M Share Common Offering at $7.75/Sh
-
Sutro Biopharma Announces Pricing of $85.3 Million Public Offering
-
Sutro Biopharma Inc. (STRO) Announces Proposed Public Offering of Common Stock
-
Sutro Biopharma Announces Proposed Public Offering
-
Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference
-
Sutro Biopharma to Present at the Cowen and Company 39th Annual Health Care Conference
-
Cowen Starts Sutro Biopharma (STRO) at Outperform
-
Sutro Biopharma (STRO) IPO Opens Modestly Higher
-
Sutro Biopharma, Inc. (STRO) Prices 5.67M Share IPO at $15/Sh
-
Sutro Biopharma Announces $85.0 Million Initial Public Offering

